Phillip Morris is a large American company founded in 1847, known for its tobacco products. In recent years, the company aims to replace cigarettes with less risky alternative products.
Syqe Medical, an Israeli company that developed the world’s first cannabis inhaler, is being acquired by American company Phillip Morris for $650 million. The deal includes an initial investment of $120 million to support the FDA approval process for the inhaler. Medical cannabis is used to treat conditions like chronic pain and chemotherapy side effects. Syqe emphasizes that its inhaler is a regulatory-approved device that allows for the safe inhalation of medicinal plants.
